Stock listing
Tvardi Therapeutics, Inc.
- Ticker
- NASDAQ:TVRD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. (TVRD) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Tvardi Therapeutics, Inc.
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
Aug 14, 2026
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
Aug 12, 2026
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
Jul 30, 2026
Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
Jul 7, 2026